We rank companies based on fund manager, research analyst and news sentiment
ALT stock icon

Altimmune
ALT

$7.58
5.38%
 

About: Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Employees: 59

0
Funds holding %
of 6,474 funds
0
Analysts bullish %
of 6 analysts
0
News positive %
of 12 articles

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

372% more capital invested

Capital invested by funds: $79.2M [Q3] → $374M (+$295M) [Q4]

112% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 25

71% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 24

54% more call options, than puts

Call options by funds: $15.3M | Put options by funds: $9.9M

25% more funds holding

Funds holding: 112 [Q3] → 140 (+28) [Q4]

4.35% more ownership

Funds ownership: 57.53% [Q3] → 61.88% (+4.35%) [Q4]

Research analyst outlook

6 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$8
6%
upside
Avg. target
$14.67
94%
upside
High target
$20
164%
upside

6 analyst ratings

positive
83%
neutral
17%
negative
0%
HC Wainwright & Co.
Patrick Trucchio
58%upside
$12
Buy
Maintained
1 Apr 2024
B. Riley Securities
Mayank Mamtani
164%upside
$20
Buy
Reiterated
28 Mar 2024
B. Riley Securities
Mayank Mamtani
164%upside
$20
Buy
Maintained
13 Feb 2024
Goldman Sachs
Corinne Jenkins
72%upside
$13
Neutral
Reinstated
24 Jan 2024
HC Wainwright & Co.
Patrick Trucchio
98%upside
$15
Buy
Reiterated
1 Dec 2023

Financial journalist opinion

Based on 12 articles about ALT published over the past 30 days